FSMDX
Price
$35.59
Change
+$0.18 (+0.51%)
Updated
Jul 16 closing price
Net Assets
42.38B
FZAMX
Price
$23.82
Change
+$0.12 (+0.51%)
Updated
Jul 16 closing price
Net Assets
1.51B
Interact to see
Advertisement

FSMDX vs FZAMX

Header iconFSMDX vs FZAMX Comparison
Open Charts FSMDX vs FZAMXBanner chart's image
Fidelity Mid Cap Index
Price$35.59
Change+$0.18 (+0.51%)
VolumeN/A
Net Assets42.38B
Fidelity Advisor Mid Cap II Z
Price$23.82
Change+$0.12 (+0.51%)
VolumeN/A
Net Assets1.51B
FSMDX vs FZAMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSMDX vs. FZAMX commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Buy and FZAMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 42.4B vs. FZAMX (1.51B). FSMDX pays higher dividends than FZAMX: FSMDX (1.31) vs FZAMX (0.54). FSMDX was incepted earlier than FZAMX: FSMDX (14 years) vs FZAMX (12 years). FZAMX (0.58) is less costly to investors than FSMDX (0.03). FZAMX is a more actively managed with annual turnover of: 52.00 vs. FSMDX (15.00). FSMDX (0) and FZAMX (0) have matching initial minimum investment requirements. FSMDX annual gain was more profitable for investors over the last year : 8.58 vs. FZAMX (-5.70). FSMDX return over 5 years is better than : 70.17 vs. FZAMX (32.10).
FSMDXFZAMXFSMDX / FZAMX
Total Expense Ratio0.030.584%
Annual Report Gross Expense Ratio0.030.584%
Fund Existence14 years12 years-
Gain YTD5.111-2.509-204%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets42.4B1.51B2,810%
Annual Yield % from dividends1.310.54243%
Returns for 1 year8.58-5.70-151%
Returns for 3 years45.9223.99191%
Returns for 5 years70.1732.10219%
Returns for 10 years117.5618.03652%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GROV1.510.08
+5.59%
Grove Collaborative Holdings
ANIK11.190.19
+1.73%
Anika Therapeutics
COMP6.580.10
+1.54%
Compass
BWA35.170.18
+0.51%
BorgWarner
ABLLL24.75-0.04
-0.16%
Abacus Global Management Inc. 9.875% Fixed Rate Senior Notes due 2028